Macquarie Group Portfolio holdings
AUM
$81.5B
1-Year Return
21.2%
This Quarter Return
-14.21%
1 Year Return
+21.2%
3 Year Return
+85%
5 Year Return
+166.7%
10 Year Return
+339.95%
AUM
$89.1B
AUM Growth
+$88.9B
(+67,643%)
Cap. Flow
-$3.31B
Cap. Flow
% of AUM
-3.71%
Top 10 Holdings %
Top 10 Hldgs %
11.59%
Holding
2,677
New
86
Increased
706
Reduced
853
Closed
102
Top Buys
| 1 |
Hologic
HOLX
|
+$302M |
| 2 |
Meta Platforms (Facebook)
META
|
+$220M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$184M |
| 4 |
NextEra Energy, Inc.
NEE
|
+$111M |
| 5 |
Generac Holdings
GNRC
|
+$88.9M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$477M |
| 2 |
Apple
AAPL
|
+$391M |
| 3 |
Viatris
VTRS
|
+$230M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$229M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$180M |
Sector Composition
| 1 | Technology | 21.36% |
| 2 | Healthcare | 15.43% |
| 3 | Financials | 13.5% |
| 4 | Industrials | 10.2% |
| 5 | Consumer Discretionary | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Sonos
SONO
$1.83B
| $1.77M | ﹤0.01% |
98,294
+31,188
| +46% | +$563K |
|
1302
Amkor Technology
AMKR
$6.29B
| $1.77M | ﹤0.01% |
104,255
| – | – |
|
1303
OFG Bancorp
OFG
$1.95B
| $1.76M | ﹤0.01% |
69,200
+8,500
| +14% | +$216K |
|
1304
Chemours
CC
$2.51B
| $1.75M | ﹤0.01% |
54,616
| – | – |
|
|
CDMO
1305
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.74M | ﹤0.01% |
114,182
+552
| +0.5% | +$8.43K |
|
1306
Universal Corp
UVV
$1.38B
| $1.74M | ﹤0.01% |
28,707
-3,517
| -11% | -$213K |
|
1307
NVR
NVR
$23.3B
| $1.73M | ﹤0.01% |
431
-4
| -0.9% | -$16K |
|
1308
M&T Bank
MTB
$31.1B
| $1.73M | ﹤0.01% |
10,821
+2,906
| +37% | +$463K |
|
1309
Karyopharm Therapeutics
KPTI
$55.9M
| $1.72M | ﹤0.01% |
25,469
| – | – |
|
1310
First Busey Corp
BUSE
$2.19B
| $1.72M | ﹤0.01% |
75,077
| – | – |
|
1311
Wabash National
WNC
$457M
| $1.71M | ﹤0.01% |
126,196
+1,320
| +1% | +$17.9K |
|
1312
Futu Holdings
FUTU
$25.9B
| $1.71M | ﹤0.01% |
32,704
+4,461
| +16% | +$233K |
|
1313
Ternium
TX
$6.8B
| $1.7M | ﹤0.01% |
47,180
| – | – |
|
1314
F5
FFIV
$18.5B
| $1.7M | ﹤0.01% |
11,085
+1,010
| +10% | +$155K |
|
1315
Allogene Therapeutics
ALLO
$251M
| $1.69M | ﹤0.01% |
148,469
| – | – |
|
1316
Nutanix
NTNX
$21.2B
| $1.68M | ﹤0.01% |
114,619
-133,126
| -54% | -$1.95M |
|
|
NBIS
1317
Nebius Group N.V. Class A Ordinary Shares
NBIS
$21.6B
| $1.68M | ﹤0.01% |
1,425,570
-60,752
| -4% | -$71.5K |
|
1318
Elastic
ESTC
$9.3B
| $1.67M | ﹤0.01% |
24,670
-2,523
| -9% | -$171K |
|
1319
Sangamo Therapeutics
SGMO
$152M
| $1.67M | ﹤0.01% |
402,135
| – | – |
|
1320
Apogee Enterprises
APOG
$903M
| $1.66M | ﹤0.01% |
42,433
-3,983
| -9% | -$156K |
|
1321
Lear
LEA
$5.62B
| $1.65M | ﹤0.01% |
13,128
-581
| -4% | -$73.2K |
|
1322
Itron
ITRI
$5.47B
| $1.64M | ﹤0.01% |
33,251
+330
| +1% | +$16.3K |
|
1323
Trane Technologies
TT
$89.2B
| $1.64M | ﹤0.01% |
12,662
-482
| -4% | -$62.6K |
|
1324
Leidos
LDOS
$23.6B
| $1.63M | ﹤0.01% |
16,163
+1,057
| +7% | +$106K |
|
1325
Mettler-Toledo International
MTD
$25.9B
| $1.62M | ﹤0.01% |
1,410
+108
| +8% | +$124K |
|